Fig. 2From: The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infectionDistribution of the MARS scores among Fabry disease patients for non-ERT drugs. The mean MARS score was 24.3 ± 1.3, while the median was 25 (range: 18–25). MARS, Medication Adherence Report ScaleBack to article page